Civica Rx, a nonprofit generic drug company founded in 2018, is trying every possible course of action in order to make insulin affordable by 2004. Earlier this month, the company announced that it will manufacture three cheaper generic insulin products – glargine, lispro and aspart.
The Food and Drug Administration (FDA) has approved Viatris’ Generic Symbicort for the treatment of asthma and chronic obstructive pulmonary disease (COPD). Symbicort is a combination of budesonide (steroid) and formoterol (β2-agonist).
In Georgia, general practitioners will be able to prescribe generic drugs to their patients, without specifying a brand of the drug, from April, according to Agenda, a Georgian news outlet. The decision aims to create a well-regulated and transparent pharmaceutical market in the nation.
The Medicines Patent Pool (MPP) has recently said that agreements to expand the global supply of Generic Paxlovid will be announced shortly. However, some countries may have to wait longer to get the generic versions of Paxlovid due to regulatory hurdles.
Teva Pharmaceuticals has recently announced the launch of its first generic version of Revlimid (lenalidomide) capsules for the treatment of multiple myeloma, certain myelodysplastic syndromes, and mantle cell lymphoma. Teva is the largest manufacturer of generic drugs.
Civica Rx, a nonprofit drug company co-founded by the Gary and Mary West Foundation in 2018, has announced that it plans to manufacture and distribute generic insulins at a low, transparent price. These low-cost generic insulins will help people with diabetes.
Generic Aadhar is one of India’s fastest-growing pharma companies. Invented by the young entrepreneur Arjun Deshpande, the company aims to offer generic drugs at an affordable price. Generic Aadhar offers generic drugs 80% less than their branded counterparts do.